Skip to content

Based on deep learning of tongue appearance and metagenomics of tongue coating microbiota, exploring the objective characterization of blood stasis syndrome in osteoporosis.

Based on deep learning of tongue appearance and metagenomics of tongue coating microbiota, exploring the objective characterization of blood stasis syndrome in osteoporosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001020
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Sponsors

Wangjing Hospital of China Academy of Traditional Chinese Medicine Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: **Study One: Inclusion Criteria for Osteoporosis Group** (1) Meets the diagnostic criteria for primary osteoporosis, based on DXA measurements of axial bones (lumbar vertebrae 1-4, femoral neck, or total hip) or the distal one-third of the radius, with a T-score = -2.5; (2) Age between 45 years and 80 years (excluding 80 years), with no gender restrictions; (3) Signed the informed consent form, and the participant voluntarily joined the study. **Inclusion Criteria for Healthy Control Group** (1) DXA measurement results show a T-score = -1.0; (2) Age between 45 years and 80 years (excluding 80 years), with no gender restrictions; (3) Signed the informed consent form, and the participant voluntarily joined the study. **Study Two: Inclusion Criteria** Based on the criteria of Study One, additional diagnostic criteria for syndrome differentiation and specific exclusion criteria for microbiome studies are added: **Inclusion Criteria for OP Blood Stasis Syndrome Group** (1) Meets the diagnostic criteria for primary OP, based on DXA measurements of lumbar vertebrae 1-4, femoral neck, or total hip, with a T-score = -2.5; (2) Meets the diagnostic criteria for blood stasis syndrome as per the "International Guidelines for the Diagnosis of Blood Stasis Syndrome," i.e., satisfies 1 major criterion or 2 minor criteria; (3) Age between 45 years and 80 years (excluding 80 years), with no gender restrictions; (4) Voluntarily participates in this clinical study and has signed the informed consent form. **Inclusion Criteria for OP Non-Blood Stasis Syndrome Group** (1) Meets the above diagnostic criteria for OP but does not satisfy any diagnostic criteria for blood stasis syndrome, as determined by two licensed TCM physicians; (2) Age between 45 years and 80 years (excluding 80 years), with no gender restrictions; (3) Voluntarily participates in this clinical study and has signed the informed consent form. **Inclusion Criteria for Healthy Control Group** (1) DXA measurement results show a T-score = -1.0, and excludes any manifestations of blood stasis syndrome; (2) Age between 45 years and 80 years (excluding 80 years), with no gender restrictions; (3) Voluntarily participates in this clinical study and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: Study One: (1) Patients with secondary osteoporosis; (2) Patients with severe cardiovascular diseases, hepatic or renal diseases, malignant tumors, or other wasting diseases, as well as infectious diseases; (3) Patients with Alzheimer's disease, mental disorders, or depression, or those unable to complete the trial; (4) Patients with other endocrine system diseases, such as Cushing's syndrome, hyperthyroidism, or hypothyroidism; (5) Patients who have taken medications affecting bone metabolism within the past 3 months, including oral or intravenous corticosteroids, or oral estrogen or progestin replacement therapy; (6) Patients currently participating in other clinical trials. Study Two: (1) Patients with severe primary diseases; (2) Patients with secondary osteoporosis; (3) Patients who have taken medications affecting bone metabolism within the past 2 weeks; (4) Patients who have taken antibiotics within the past 2 weeks; (5) Patients with oral diseases such as oral ulcers, glossitis, or periodontitis; (6) Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Tongue Coating Image;Oral microbiota;

Secondary

MeasureTime frame
25-hydroxyvitamin D;Osteocalcin;P1NP;Parathyroid Hormone;Fasting Blood Glucose;glycated hemoglobin;C-peptide;Insulin;Cholesterol;Triglyceride;High-Density Lipoprotein;Low-Density Lipoprotein;

Countries

China

Contacts

Public ContactLu Jiajin

Wangjing Hospital of China Academy of Traditional Chinese Medicine Sciences

1246105871@qq.com19801165731

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026